Conventional bioprinting places cells to construct form. This invention proposes the inverse: place one fiber, and living tissue wraps it spontaneously. The Self-Integrating Bioconductive Myofiber (SIBM) is a scaffold fiber designed so that cardiomyocytes, fibroblasts, and vascular endothelial cells adhere and encapsulate each fiber autonomously. Three surface elements drive self-integration: (1) Cell adhesion factor coating — fibronectin, laminin, collagen IV at nanoscale density activates integrin-mediated adhesion; (2) Inductive microcurrent — piezoelectric fiber generates micro-ampere currents that electrophoretically attract cells (same principle as wound healing currents); (3) Nanoscale surface texture — 100-500nm groove structures guide cell alignment via contact guidance, spontaneously reproducing the helical myocardial fiber orientation. Once flesh wraps the fiber, electrical contact is established: fiber electricity drives cell contraction, contraction drives piezoelectric generation — the system becomes self-sustaining the moment of encapsulation. SIBM is the third layer of a three-part invention series: ECCE (what to build, DOI: 10.5281/zenodo.20725907), CPMH (how to build, DOI: 10.5281/zenodo.20725945), SIBM (why it lives). Theoretical basis: V = N / D — when flesh wraps the fiber, external intervention (D) approaches zero and biological density (N) is maximized. The designer places the fiber. The flesh does the rest. Inventor declaration: The inventor does not manufacture this device. Published as open knowledge base for all regenerative medicine researchers, materials scientists, and cardiac surgeons.
Yoshimitsu Katayama (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: